Artículos por temáticas

Urodynamic study for distinguishing multiple system atrophy from Parkinson disease.

Shin JH, Park KW, Heo KO, Chung SJ, Choo MS.

Neurology. 2019 Sep 3;93(10):e946-e953. doi: 10.1212/WNL.0000000000008053. Epub 2019 Aug 1.

Depression, quality of life, activities of daily living, and subjective memory after deep brain stimulation in Parkinson disease-A reliable change index analysis.

Pusswald G, Wiesbauer P, Pirker W, Novak K, Foki T, Lehrner J.

Int J Geriatr Psychiatry. 2019 Jul 31. doi: 10.1002/gps.5184. [Epub ahead of print]

Pseudoxanthoma elasticum presenting as akinetic-rigid parkinsonism and dementia.

Souza PVS, Badia BML, Pinto WBVR, Oliveira ASB, Silva LHL, Seneor DD, Marin VDGB, Teixeira Júnior CAC, Chieia MAT, Farias IB.

Arq Neuropsiquiatr. 2019 Jul 29;77(7):525-526. doi: 10.1590/0004-282X20190075. No abstract available.

Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism.

Honkanen EA, Kemppainen N, Noponen T, Seppänen M, Joutsa J, Kaasinen V.

Clin Neuropharmacol. 2019 Jul 29. doi: 10.1097/WNF.0000000000000359. [Epub ahead of print]

Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing.

Haq IU, Snively BM, Sweadner KJ, Suerken CK, Cook JF, Ozelius LJ, Miller C, McCall WV, Whitlow CT, Brashear A.

Mov Disord. 2019 Jul 30. doi: 10.1002/mds.27801. [Epub ahead of print]

Resistance training reduces depressive symptoms in elderly people with Parkinson disease: A controlled randomized study.

de Lima TA, Ferreira-Moraes R, Alves WMGDC, Alves TGG, Pimentel CP, Sousa EC, Abrahin O, Cortinhas-Alves EA.

Scand J Med Sci Sports. 2019 Jul 29. doi: 10.1111/sms.13528. [Epub ahead of print]

Parkinson Disease.

Zesiewicz TA.

Continuum (Minneap Minn). 2019 Aug;25(4):896-918. doi: 10.1212/CON.0000000000000764.

Activation of mGlu(2/3) receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism.

Frouni I, Hamadjida A, Kwan C, Bédard D, Nafade V, Gaudette F, Nuara SG, Gourdon JC, Beaudry F, Huot P.

Neuropharmacology. 2019 Nov 1;158:107725. doi: 10.1016/j.neuropharm.2019.107725. Epub 2019 Jul 25.

MRI Signal Intensity and Parkinsonism in Manganese-Exposed Workers.

Criswell SR, Nielsen SS, Warden MN, Flores HP, Lenox-Krug J, Racette S, Sheppard L, Checkoway H, Racette BA.

J Occup Environ Med. 2019 Aug;61(8):641-645. doi: 10.1097/JOM.0000000000001634.

Trends in the Prevalence of Drug-Induced Parkinsonism in Korea.

Byun JH, Cho H, Kim YJ, Kim JS, Baik JS, Jang S, Ma HI.

Yonsei Med J. 2019 Aug;60(8):760-767. doi: 10.3349/ymj.2019.60.8.760.

Low Back Pain-Related Disability in Parkinson Disease: Impact on Functional Mobility, Physical Activity, and Quality of Life.

Duncan RP, Van Dillen LR, Garbutt JM, Earhart GM, Perlmutter JS.

Phys Ther. 2019 Jul 25. pii: pzz094. doi: 10.1093/ptj/pzz094. [Epub ahead of print]

Dermatoses in parkinsonism: the importance of multidisciplinary follow-up.

Antunes I, Purim KSM, Grande LL, Alberton NC, Navarro TFR, Winckler TCD.

Rev Assoc Med Bras (1992). 2019 Jul 22;65(6):791-795. doi: 10.1590/1806-9282.65.6.791.

Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach.

Bougea A, Spantideas N, Katoulis A, Stefanis L.

Acta Neurol Belg. 2019 Sep;119(3):325-336. doi: 10.1007/s13760-019-01195-3. Epub 2019 Jul 23.

Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease.

Carmona-Abellan M, Martínez-Valbuena I, DiCaudo C, Marcilla I, Luquin MR.

Clin Auton Res. 2019 Aug;29(4):415-425. doi: 10.1007/s10286-019-00620-0. Epub 2019 Jul 23.

Yoga for Anxiety and Depression Associated With Parkinson Disease.

Slomski A.

JAMA. 2019 Jul 23;322(4):296. doi: 10.1001/jama.2019.10369. No abstract available.